Nexthera Capital as of March 31, 2019
Portfolio Holdings for Nexthera Capital
Nexthera Capital holds 24 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Audentes Therapeutics | 11.9 | $9.8M | 251k | 39.02 | |
| Heron Therapeutics (HRTX) | 11.5 | $9.5M | 389k | 24.44 | |
| Insmed (INSM) | 10.0 | $8.3M | 284k | 29.07 | |
| Immunomedics | 7.8 | $6.4M | 335k | 19.21 | |
| Bausch Health Companies (BHC) | 6.2 | $5.1M | 206k | 24.70 | |
| Urogen Pharma (URGN) | 5.9 | $4.9M | 133k | 36.94 | |
| Global Blood Therapeutics In | 5.6 | $4.6M | 87k | 52.93 | |
| D Stemline Therapeutics | 5.1 | $4.2M | 326k | 12.85 | |
| Novartis (NVS) | 4.7 | $3.8M | 45k | 84.58 | |
| Amarin Corporation (AMRN) | 3.8 | $3.1M | 149k | 20.76 | |
| Cymabay Therapeutics | 3.4 | $2.8M | 210k | 13.28 | |
| Sarepta Therapeutics (SRPT) | 3.1 | $2.5M | 21k | 119.18 | |
| Uniqure Nv (QURE) | 2.8 | $2.3M | 39k | 59.64 | |
| Exelixis (EXEL) | 2.6 | $2.1M | 90k | 23.79 | |
| Neurocrine Biosciences (NBIX) | 2.6 | $2.1M | 24k | 88.10 | |
| Acorda Therapeutics | 2.5 | $2.1M | 155k | 13.29 | |
| Allergan | 2.4 | $2.0M | 14k | 146.42 | |
| Intercept Pharmaceuticals In | 1.6 | $1.3M | 12k | 111.86 | |
| Kiniksa Pharmaceuticals | 1.5 | $1.2M | 68k | 18.07 | |
| Chiasma | 1.3 | $1.1M | 204k | 5.20 | |
| Deciphera Pharmaceuticals | 1.2 | $995k | 43k | 23.21 | |
| Sage Therapeutics (SAGE) | 1.2 | $986k | 6.2k | 159.03 | |
| BioMarin Pharmaceutical (BMRN) | 0.9 | $733k | 8.3k | 88.85 | |
| Madrigal Pharmaceuticals (MDGL) | 0.5 | $432k | 3.5k | 125.14 |
